In summary, this study revealed that compared with para-cancerous tissues, P2RX1 expression in a variety of tumors, including BC, was significantly decreased, and the P2RX1 expression level was strongly associated with clinical outcomes. The gene discussed is P2RX1; the disease is breast cancer.